tiprankstipranks
Trending News
More News >
CARGO Therapeutics, Inc. (CRGX)
:CRGX
US Market
CRGX
CARGO Therapeutics, Inc.
RESEARCH TOOLSreports

CARGO Therapeutics, Inc. (CRGX) Price & Analysis

Compare
Followers

CRGX Stock Chart & Stats

$4.47
-$0.07(-1.54%)
--

CARGO Therapeutics, Inc. News

CRGX FAQ

What was CARGO Therapeutics, Inc.’s price range in the past 12 months?
Currently, no data Available
What is CARGO Therapeutics, Inc.’s market cap?
Currently, no data Available
When is CARGO Therapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CARGO Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is CARGO Therapeutics, Inc. overvalued?
According to Wall Street analysts CARGO Therapeutics, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does CARGO Therapeutics, Inc. pay dividends?
    CARGO Therapeutics, Inc. does not currently pay dividends.
    What is CARGO Therapeutics, Inc.’s EPS estimate?
    CARGO Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does CARGO Therapeutics, Inc. have?
    Currently, no data Available
    What happened to CARGO Therapeutics, Inc.’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of CARGO Therapeutics, Inc.?
    Currently, no hedge funds are holding shares in CRGX
    What is the TipRanks Smart Score and how is it calculated?
    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

      Company Description

      CARGO Therapeutics, Inc.

      CARGO Therapeutics, Inc. (CRGX) is a biotechnology company focused on developing advanced therapies in the field of oncology. The company specializes in creating innovative chimeric antigen receptor T-cell (CAR-T) therapies designed to target and eliminate cancer cells. Operating within the biotechnology and healthcare sectors, CARGO Therapeutics is committed to advancing cancer treatment through cutting-edge research and clinical trials aimed at providing patients with effective and personalized therapeutic options.

      Ownership Overview

      0.17%99.83%
      Insiders
      0.17%
      Mutual Funds
      ― Other Institutional Investors
      99.83% Public Companies and
      Individual Investors

      Options Prices

      Currently, No data available
      ---
      Popular Stocks